Form 4: Clover Health Executive Sells Shares for Tax Obligations Following RSU Vesting

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., reported the disposition of Class A Common Stock shares to cover tax obligations related to the vesting of restricted stock units.

Summary

• Jamie L. Reynoso, CEO, Medicare Advantage of Clover Health Investments, Corp. (CLOV), filed a Form 4 reporting changes in beneficial ownership.
• On June 14, 2025, 12,567 shares of Class A Common Stock were disposed of at a price of $2.89 per share. This disposition was to cover tax obligations upon the vesting of 6.25% of time-based restricted stock units (RSUs) granted on March 14, 2022.
• Following this transaction, Jamie L. Reynoso beneficially owned 3,225,542 shares of Class A Common Stock.
• On June 15, 2025, an additional 8,691 shares of Class A Common Stock were disposed of at a price of $2.89 per share. This disposition also covered tax obligations upon the vesting of 6.25% of time-based RSUs granted on September 16, 2022.
• After both reported transactions, Jamie L. Reynoso's beneficial ownership of Class A Common Stock stood at 3,216,851 shares.
• The remaining RSUs from the March 14, 2022 grant are scheduled to vest quarterly in equal installments of 6.25%, with a final vesting date on March 14, 2026, subject to continued service.
• The remaining RSUs from the September 16, 2022 grant are scheduled to vest quarterly in equal installments of 6.25%, with a final vesting date on September 15, 2026, subject to continued service.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document reports routine insider transactions related to executive compensation (RSU vesting and tax withholding), which are standard and expected, providing no significant positive or negative implications for the company's operational or financial performance.

Positives

• The vesting of restricted stock units (RSUs) indicates the continued employment and long-term incentive alignment of a key executive, Jamie L. Reynoso, with the company's performance.
• The transactions are routine tax withholdings, which are a standard part of executive compensation plans and do not indicate a discretionary sale by the executive.

Negatives

• The disposition of shares, even for tax purposes, results in a reduction of the executive's direct beneficial ownership in the company.

Future Outlook

The document indicates a future outlook of continued RSU vesting for Jamie L. Reynoso, with remaining installments vesting quarterly until final dates of March 14, 2026, and September 15, 2026, contingent upon the reporting person's continued service to the company.

Industry Context

This Form 4 filing represents a routine insider transaction related to executive compensation, specifically the vesting of restricted stock units and the subsequent sale of shares to cover tax obligations. This practice is common across various industries, including the healthcare and technology sectors where Clover Health operates, and reflects standard compensation structures designed to align executive interests with shareholder value over time.

Comparison to Industry Standards

• The practice of granting Restricted Stock Units (RSUs) as a component of executive compensation is a widely adopted standard across publicly traded companies, including those in the healthcare and technology sectors.
• The automatic withholding of shares to cover tax obligations upon RSU vesting is a common and standard procedure, often referred to as 'net settlement,' which is designed to simplify the tax compliance process for both the company and the executive.
• The vesting schedule, with quarterly installments over several years, is typical for long-term incentive plans, similar to those seen at comparable companies like Humana Inc. (HUM) or UnitedHealth Group Inc. (UNH) in the Medicare Advantage space, or tech-enabled healthcare companies like Teladoc Health, Inc. (TDOC), aiming to retain talent and incentivize sustained performance.

Stakeholder Impact

• Shareholders: The disposition of shares for tax purposes represents a minor, routine dilution event. However, the underlying RSU vesting indicates continued alignment of executive incentives with shareholder value.
• Employees: The filing reflects standard executive compensation practices, which can serve as a benchmark for other employees' long-term incentive plans.

Next Steps

• Future quarterly vesting installments of restricted stock units for Jamie L. Reynoso, with final vesting dates on March 14, 2026, and September 15, 2026, subject to continued service.

Key Dates

Recommendation

Keywords

Clover Health, CLOV, SEC Form 4, insider transaction, restricted stock units, RSU vesting, tax withholding, beneficial ownership, executive compensation, Jamie L. Reynoso, Medicare Advantage